20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9575 | MRTX9768 | Histone Methyltransferase | |
MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors. | |||
T8227 | 5'-Methylthioadenosine | Methylthioadenosine,5'-(Methylthio)-5'-deoxyadenosine,5'-Deoxy-5'-(methylthio)adenosine,5'-S-Methyl-5'-thioadenosine | Endogenous Metabolite |
5'-Methylthioadenosine (Methylthioadenosine) is produced from S-adenosylmethionine and behaves as a powful inhibitory product. | |||
T14141 | AGI-24512 | Others , Methionine Adenosyltransferase (MAT) | |
AGI-24512 is a inhibitor of methionine adenosyltransferase 2A (MATA2 ).It is useful for treatment of cancer and blocks growth of MTAP-deleted cancer cells in vitro. | |||
TQ0008 | MT-DADMe-ImmA | Methylthio-DADMe-Immucillin A,MTDIA | Others |
MT-DADMe-ImmA (MTDIA) is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP, Ki: 90 pM). | |||
T73494 | TNG908 | ||
TNG908, a MTAP-cooperative PRMT5 inhibitor capable of penetrating the blood-brain barrier, demonstrates 15-fold greater selectivity for MTAP cell lines over MTAP WT (wild type) cell lines. Its application is primarily in... | |||
T40254 | MRTX-1719 | Histone Methyltransferase | |
MRTX-1719 is a potent, first-in-class, selective inhibitor of the PRMT5/MTA complex, with an IC50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells. | |||
T31672 | Erythrofuranosyladenine | 9-β-D-Erythrofuranosyladenine,ETA | |
Erythrofuranosyladenine(9-beta-D-Erythrofuranosyladenine, ETA) is a nontoxic MTAP substrate. Erythrofuranosyladenine is an effective salvage agent for methylthioadenosine phosphorylase–selective therapy of T-cell acute l... | |||
T33517 | MTDIA HCl | MTDIA,Methylthio-DADMe-Immucillin A,MT-DADMe-ImmA,MT-DADMe-ImmA HCl | |
MTDIA (MT-DADMe-ImmA and methylthio-DADMe-Immucillin A) is an MTAP inhibitor. | |||
T15691 | L-Alanosine | NSC-153353 | Others |
L-Alanosine inhibits adenylosuccinate synthetase. L-Alanosine is an antibiotic from Streptomyces alanosinicus with antineoplastic activity. L-Alanosine blocks the common de novo purine biosynthesis pathway and, thereby, ... | |||
T79873 | TNG-462 | Histone Methyltransferase | |
TNG-462 (Compound 1143) is a PRMT5 inhibitor with oral activity, being investigated for use in MTAP-deficient and/or MTA-accumulating cancers [1]. | |||
T36630 | MRTX9768 hydrochloride | ||
MRTX9768 hydrochloride is a potent, orally active PRMT5 inhibitor. MRTX9768 hydrochloride is a synthetic lethal-based inhibitor binding the PRMT5-MTA complex[1]. MRTX9768 inhibits SDMA and cell proliferation in HCT116 MT... | |||
T10259 | AGI-25696 | Others , Methionine Adenosyltransferase (MAT) | |
AGI-25696 is an inhibitor of methionine adenosyltransferase 2A (MATA2). AGI-25696 blocks the growth of MTAP-deleted tumors in vivo and can be used for studies about the treatment of cancer. | |||
T69811 | AGI25696 | ||
AGI-25696 is a MATA2 inhibitor that are useful as therapeutic agents for treating malignancies. AGI-25696 showed in vivo activity in MTAP null tumors. Note: The correct structure of AGI-25696 is CAS#2201065-84-9. Many ve... | |||
T79350 | MAT2A-IN-12 | Methionine Adenosyltransferase (MAT) | |
MAT2A Allosteric Inhibitor 2 is a potent, selective inhibitor exhibiting an IC50 of 5 nM and demonstrates nanomolar efficacy (IC50 = 5 μM) in proliferation assays utilizing the MTAP -/- cell line [1]. | |||
T63975 | MAT2A-IN-1 | ||
MAT2A-IN-1 is a potent inhibitor of MAT2A and is capable of proliferative activity in MTAP-deficient cancer cells. MAT2A is expressed at unusually high levels in several tumour types, including gastric, colon, liver and ... | |||
T62100 | MAT2A-IN-6 | ||
MAT2A-IN-6 is a potent inhibitor of MAT2A. MAT2A-IN-6 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-6 has shown potential research value in cancer diseases. | |||
T61243 | MAT2A-IN-5 | ||
MAT2A-IN-5, a potent inhibitor of MAT2A, effectively targets the abnormally elevated expression of MAT2A found in various tumor types such as gastric, colon, liver, and pancreatic cancers. By reducing the proliferative a... | |||
T63603 | MAT2A-IN-3 | ||
MAT2A-IN-3 is a potent inhibitor of MAT2A. MAT2A-IN-3 inhibits the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-3 has shown research potential for cancer diseases. | |||
T61672 | MAT2A-IN-7 | ||
MAT2A-IN-7, a potent inhibitor of the enzyme MAT2A, demonstrates efficacy in targeting the abnormally elevated expression of MAT2A observed in gastric, colon, liver, and pancreatic cancers. Furthermore, MAT2A-IN-7 effect... | |||
T62984 | MAT2A-IN-2 | ||
MAT2A-IN-2 is a potent inhibitor of MAT2A. MAT2A-IN-2 has potential for cancer disease research. |